Journal of Thrombosis and Thrombolysis

, Volume 24, Issue 3, pp 323–325 | Cite as

Thrombotic preparedness in aging: a translatable construct for thrombophilias?

  • Richard C. Becker

The association between aging and atherothrombotic phenotypes, to include myocardial infarction and ischemic stroke, is well described and represents a phenomenon of heightened societal relevance given the progressive increase in life-expectancy in western societies. Fundamentally, the prothrombotic state of aging displays teleological similarities to other conditions wherein hemostatic challenges are anticipated and, in essence, prepared for through several related molecular and biological mechanisms. In aging, however, maladaptive vascular responses mediated by impaired endothelial cell regenerative capacity, cause a dangerous shift toward thrombosis that persists and is further augmented over time. A common and unifying theme of vascular injury and faulty repair in all likelihood participates directly in concomitant thrombotic and hemorrhagic risk among older individuals as well. Accordingly, therapies designed to prevent vascular injury, restore reparative capacity or both, may be...


  1. 1.
    Franchini M (2006) Hemostasis and aging. Crit Rev Oncol Hematol 60:144–151PubMedCrossRefGoogle Scholar
  2. 2.
    Bauer KA, Weiss LM, Sparrow D, Vokonas PS, Rosenberg RD (1987) Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative aging study. J Clin Invest 80:1527–1534PubMedCrossRefGoogle Scholar
  3. 3.
    Bauer KA, Kass BL, ten Cate H, Bednarek MA, Hawiger JJ, Rosenberg RD (1989) Detection of factor X activation in humans. Blood 74:2007–2015PubMedGoogle Scholar
  4. 4.
    Bauer KA, Kass BL, ten Cate H, Hawiger JJ, Rosenberg RD (1990) Factor IX is activated in vivo by the tissue factor mechanism. Blood 76:731–736PubMedGoogle Scholar
  5. 5.
    Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD (1995) Hypercoagulability in centenarians: the paradox of successful aging. Blood 85:3144–3149PubMedGoogle Scholar
  6. 6.
    Bastyr EJ 3rd, Kadrofske MM, Vinik AI (1990) Platelet activity and phosphoinositide turnover increase with advancing age. Am J Med 88:601–606PubMedCrossRefGoogle Scholar
  7. 7.
    Reilly IA, FitzGerald GA (1986) Eicosenoid biosynthesis and platelet function with advancing age. Thromb Res 41:545–554PubMedCrossRefGoogle Scholar
  8. 8.
    Tofler GH, Massaro J, Levy D et al (2005) Relation of the prothrombotic state to increasing age (from the Framingham offspring study). Am J Cardiol 96:1280–1283PubMedCrossRefGoogle Scholar
  9. 9.
    Lutsey PL, Cushman M, Steffen LM et al (2006) Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study. J Thromb Haemost 4:2629–2635PubMedCrossRefGoogle Scholar
  10. 10.
    Rauscher FM, Goldschmidt-Clermont PJ, Davis BH et al (2003) Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108:457–463PubMedCrossRefGoogle Scholar
  11. 11.
    Karra R, Vemullapalli S, Dong C et al (2005) Molecular evidence for arterial repair in atherosclerosis. Proc Natl Acad Sci USA 102:16789–16794PubMedCrossRefGoogle Scholar
  12. 12.
    Zhu S, Liu X, Li Y, Goldschmidt-Clermont PJ, Dong C (2007) Aging in the atherosclerosis milieu may accelerate the consumption of bone marrow endothelial progenitor cells. Arterioscler Thromb Vasc Biol 27:113–119PubMedCrossRefGoogle Scholar
  13. 13.
    Schmidt-Lucke C, Rossig L, Fichtlscherer S et al (2005) Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111:2981–2987PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Duke Clinical Research InstituteDurhamUSA

Personalised recommendations